Mount Sinai scientists have developed a machine learning tool that predicts cardiovascular disease risk in patients with obstructive sleep apnea, using CPAP treatment data. This advancement allows for personalized medicine approaches, helping tailor treatments to individual patient needs and potentially reducing risks for those most likely to benefit from CPAP therapy.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



